TORONTO, CANADA – Cynapsus Therapeutics Inc. (CTH: TSX-V) (CYNAF: OTCQX), a specialty pharmaceutical company, today announced positive data from its recently completed CTH-104 healthy volunteer pilot ...
CAMBRIDGE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing medicines for broad populations of cancer patients with an ...
Please provide your email address to receive an email when new articles are posted on . Aviceda Therapeutics has completed enrollment of its phase 2b SIGLEC study, which will compare the safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results